1/3 MSK is proud to highlight two outstanding early-career physician-scientists presenting at #AACR25: Dr. @kevinmboehm and Dr. @scgerstberger — rising stars in the next generation of #cancerresearch.
Organ preservation is possible in a high proportion of patients with dMMR/MSI-H tumors with neoadjuvant PD-1 blockade. Incredible work by @AndreaCercek@MikeFooteMD Luis Diaz at @MSKCancerCenter
At #AACR25, stop by medical oncology fellow @scgerstberger's poster to learn about her study that evaluated how colibactin-producing E.coli bacteria may contribute to early-onset #colorectalcancer by damaging DNA. @MSKCancerCenter@AACR
Learn more: https://t.co/mjWAsbA4Dn
Congratulations to medical oncology fellow @scgerstberger for receiving the @AACR Women in Cancer Research Scholar Award! 🎉 #AACR25
Learn more about her fascinating work investigating #phenotypic plasticity and chemo resistance in colorectal cancer here: https://t.co/Nm1gBT3S5g
A study from the #TuschlLab offers proof-of-concept that a new class of antivirals could be a powerful new weapon to fight COVID. The work opens the door to more antiviral treatments against other diseases like Ebola and dengue, also caused by RNA viruses. https://t.co/m2gVPVKuqE
Congratulations to this year's class of Conquer Cancer Grant and Award recipients! We can't wait to celebrate with you at #ASCO24! Full list of recipients: https://t.co/mCaRLSVLik
In a plenary session at #AACR24, Dr. @dana_peer highlighted three recent research collaborations between her and other labs at MSK that have shed new light on the ability of #cancer cells to adapt and spread. Learn more: (@AACR) https://t.co/pWHuA9feSG https://t.co/zgrNH0aY1l
Join Dr. @dana_peer for a plenary session about charting the awesome power of plasticity during #metastasis TODAY at #AACR24 (@AACR) Learn more: https://t.co/8Afy6dSFpQ
A piece of years of hard labor and dedication, none of it possible without the amazing support of @KarunaGaneshLab@fsanchezvega and the incredible mentorship of @KarunaMDPhD
Medical fellow Stefanie Gerstberger presents her research on how colibactin mutation signatures are associated with younger age of onset in #colorectalcancer during a Poster session at #AACR24. Learn more:https://t.co/44UPc3YHWN